Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli
Francesca Zerbini1, Ilaria Zanella1, Davide Fraccascia1
1Synthetic and Structural Vaccinology Unit, CIBIO, University of Trento, Via Sommarive, 9, Povo, 38123, Trento, Italy.
Microbial Cell Factories
|April 26, 2017
Summary
This study optimized CRISPR/Cas9 genome editing in E. coli, achieving 100% robustness for gene deletions using double-stranded DNA donors. The new protocol ensures high efficiency for both single and multiple gene targets in high-throughput applications.
Area of Science:
- Microbiology
- Molecular Biology
- Synthetic Biology
Background:
- CRISPR/Cas9 and lambda (λ) recombinase-mediated recombineering are key for E. coli genome editing.
- Previous studies showed high mutagenesis efficiency but lacked data on robustness for large-scale applications.
Purpose of the Study:
- To define a robust, simple, and rapid protocol for single or multiple gene deletions in E. coli.
- To validate the robustness of CRISPR/Cas9 genome editing across a large number of targeted loci.
Main Methods:
- Optimized CRISPR/Cas9 protocol by testing guide RNA sequences, donor DNA length/concentration, and single/double-stranded donors.
- Validated optimized conditions by targeting 78 dispensable genes for deletion.
Main Results:
- Developed a protocol using double-stranded synthetic donor DNAs with consistently >10% mutagenesis efficiency.
- Achieved 100% robustness, meaning all targeted loci were successfully mutated.
- Demonstrated applicability for simultaneous gene deletions.
Conclusions:
- This work establishes the robustness of a CRISPR/Cas9 protocol for bacterial genome editing using a large sample size.
- The proposed protocol is suitable for high-throughput genome editing in synthetic biology.
- The findings have broad applicability for researchers in bacterial genome engineering.
Related Concept Videos
CRISPR/Cas9 Genome Editing
2.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.2K
CRISPR
58.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.4K


